CompletedPHASE1, PHASE2NCT00303849
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
Studying Anaplastic oligoastrocytoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- OHSU Knight Cancer Institute
- Principal Investigator
- Edward A NeuweltOHSU Knight Cancer Institute
- Intervention
- Carboplatin(drug)
- Enrollment
- 33 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2005 – 2021
Study locations (2)
- University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
- OHSU Knight Cancer Institute, Portland, Oregon, United States
Collaborators
Oregon Health and Science University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00303849 on ClinicalTrials.gov